Synthesis and properties of a novel phosphodiester analogue, nucleoside boranophosphorothioate

Chemical Communications

Volumn , Issue 16, 1999, Pages 1517-1518

  Lin, Jinlai ^a   Shaw, Barbara Ramsay ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE; PHOSPHOROTHIOIC ACID DERIVATIVE;

ARTICLE; LIPOPHILICITY; SOLUBILITY; SYNTHESIS;

EID: 0033592104     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/a901157i     Document Type: Article

References (26)

1. F. Eckstein, Angew. Chem., Int. Ed. Engl., 1983, 22, 423.
2. Antisense Therapeutic: Progress and Prospect, ed. G. L. Trainor, ESCOM Science Publishers, The Netherlands, 1996, pp. 1-85.
3. M. Egli, Angew. Chem., Int. Ed. Engl., 1996, 35, 1894; E. Uhlmann and A. Peyman, Chem. Rev., 1990, 90, 543.
4. M. Egli, Angew. Chem., Int. Ed. Engl., 1996, 35, 1894; E. Uhlmann and A. Peyman, Chem. Rev., 1990, 90, 543.
5. S. T. Crooke and C. F. Bennett, Annu. Rev. Pharmacol. Toxicol., 1996, 36, 107.
6. F. Eckstein, Annu. Rev. Biochem., 1985, 54, 367.
7. (a) A. Sood, B. R. Shaw and B. F. Spielvogel, J. Am. Chem. Soc., 1990, 112, 9000;
8. (b) J. Tomasz, B. R. Shaw, K. Porter, B. F. Spielvogel and A. Sood, Angew. Chem., Int. Ed. Engl., 1992, 31, 1373;
9. (c) B. R. Shaw, J. Madison, A. Sood and B. F. Spielvogel, Methods Mol. Biol., 1993, 20, 225;
10. (d) H. Li, C. Hardin and B. R. Shaw, J. Am. Chem. Soc., 1996, 118, 6606;
11. (e) K. W. Porter, J. D. Briley, B. R. Shaw, Nucleic Acids Res., 1997, 25, 1611;
12. (f) F. Huang, A. Sood, B. F. Spielvogel and B. R. Shaw, J. Biomol. Struct. Dynam., 1993, 10, a078;
13. (g) D. S. Sergueev and B. R. Shaw, J. Am. Chem. Soc., 1998, 120, 9417.
14. V. Rait and B. R. Shaw, Antisense Nucleic Acid Drug Dev., 1999, 9, 53; B. R. Shaw, in Papers from the 5th Annual International Conference on Antisense: DNA and RNA Based Therapeutics. IBC, Southborough, MA, 1998, pp. 1-8; RNase H activity was mentioned by Higson et al. (A. P. Higson, A. Sierzchala, H. Brummel, Z.-G. Zhao and M. H. Caruthers, Tetrahedron Lett., 1998, 39, 3899), but no data were shown.
15. V. Rait and B. R. Shaw, Antisense Nucleic Acid Drug Dev., 1999, 9, 53; B. R. Shaw, in Papers from the 5th Annual International Conference on Antisense: DNA and RNA Based Therapeutics. IBC, Southborough, MA, 1998, pp. 1-8; RNase H activity was mentioned by Higson et al. (A. P. Higson, A. Sierzchala, H. Brummel, Z.-G. Zhao and M. H. Caruthers, Tetrahedron Lett., 1998, 39, 3899), but no data were shown.
16. V. Rait and B. R. Shaw, Antisense Nucleic Acid Drug Dev., 1999, 9, 53; B. R. Shaw, in Papers from the 5th Annual International Conference on Antisense: DNA and RNA Based Therapeutics. IBC, Southborough, MA, 1998, pp. 1-8; RNase H activity was mentioned by Higson et al. (A. P. Higson, A. Sierzchala, H. Brummel, Z.-G. Zhao and M. H. Caruthers, Tetrahedron Lett., 1998, 39, 3899), but no data were shown.
17. S. Agrawal, Trends Biotechnol., 1996, 14, 376.
18. C. Lehmann, Y.-Z. Xu, C. Christodoulou, Z.-K. Tan and M. J. Gait, Nucleic Acids Res., 1989, 17, 2379.
19. R (6b) = 32.52 min.
20. (a) P. S. Sarin, S. Agrawal, M. P. Civéira, J. Goodchild, T. Ikeuchi and P. C. Zamecnik, Proc. Natl. Acad. Sci. USA, 1988, 85, 7448;
21. (b) D. M. Tidd, Anticancer Res., 1990, 10, 1169;
22. (c) K. L. Agarwal and F. Riftina, Nucleic Acids Res., 1979, 6, 3009;
23. (d) P. M. J. Burgers and F. Eckstein, Biochemistry, 1979, 18, 592.
24. BT was 320 times greater than that of TpT.
25. C. McGuigan, D. Cahard, A. Salgado, E. De Clercq and J. Balzarini, Antiviral Chem. Chemother., 1996, 7, 31.
26. M. F. Hawthorne, Angew. Chem., Int. Ed. Engl., 1993, 32, 950.